Skip to main content
Erschienen in: World Journal of Urology 6/2011

01.12.2011 | Original Article

The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert

verfasst von: David Schilling, Georgios Gakis, Ute Walcher, Arnulf Stenzl, Udo Nagele

Erschienen in: World Journal of Urology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to compare a novice surgeon with an expert surgeon independently performing minimally invasive percutaneous neprolitholapaxy (PCNL) excluding the influence of the expert in the learning curve.

Methods

Clinical records of 84 patients (novice: n = 35; expert: n = 49) undergoing minimally invasive PCNL between 04/2007 and 04/2008 were retrospectively reviewed for the following parameters: drop in hemoglobin, operative and fluoroscopy time, length of hospital stay, stone-free rate and complication rate. Complications were graded according to the Clavien classification. Statistical analysis was carried out by student’s t test (Chi-square test) with p < 0.05 considered significant.

Results

The novice surgeon experienced longer median operative and fluoroscopy time, lower stone-free rate and higher re-treatment rate (all p < 0.005) but no longer length of hospital stay (p = 0.19) compared to the experienced surgeon. The novice showed a notable improvement in operating time (p = 0.0208). Altogether, 16 complications occurred in 84 minimally invasive PCNL (19.1%) with five patients (6.0%) encountering grade III complications. Four patients (8.2%) treated by the expert surgeon developed complications (all grade I/II) compared to 12 of the patients (34.3%) treated by the novice surgeon (p = 0.0265). All grade III complications occurred in the first 20 patients of the novice surgeon group.

Conclusions

Despite longer operating time and a lower initial stone-free rate, the novice showed a significant improvement with growing experience and a low rate of higher grade (≥IIIa) complications. This demonstrates that the concept of minimally invasive PCNL can also be learned by urologists who do not have the support of an experienced colleague without endangering patient safety.
Literatur
1.
Zurück zum Zitat Allen D, O’Brien T, Tiptaft R et al (2005) Defining the learning curve for percutaneous nephrolithotomy. J Endourol 19:279–282PubMedCrossRef Allen D, O’Brien T, Tiptaft R et al (2005) Defining the learning curve for percutaneous nephrolithotomy. J Endourol 19:279–282PubMedCrossRef
2.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef
3.
Zurück zum Zitat Feng MI, Tamaddon K, Mikhail A et al (2001) Prospective randomized study of various techniques of percutaneous nephrolithotomy. Urology 58:345–350PubMedCrossRef Feng MI, Tamaddon K, Mikhail A et al (2001) Prospective randomized study of various techniques of percutaneous nephrolithotomy. Urology 58:345–350PubMedCrossRef
4.
Zurück zum Zitat Hacker A, Wendt-Nordahl G, Honeck P et al (2007) A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol 21:545–550PubMedCrossRef Hacker A, Wendt-Nordahl G, Honeck P et al (2007) A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol 21:545–550PubMedCrossRef
5.
Zurück zum Zitat Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906PubMedCrossRef Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906PubMedCrossRef
6.
Zurück zum Zitat Nagele U, Anastasiadis AG, Schilling DA et al (2007) Introducing a new sealant applicator for easy, safe, and quick closure of a mini-percutaneous nephrolitholapaxy access tract. J Endourol 21:393–396PubMedCrossRef Nagele U, Anastasiadis AG, Schilling DA et al (2007) Introducing a new sealant applicator for easy, safe, and quick closure of a mini-percutaneous nephrolitholapaxy access tract. J Endourol 21:393–396PubMedCrossRef
7.
Zurück zum Zitat Nagele U, Horstmann M, Sievert KD et al (2007) A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in vitro pressure-measurement and microscopic study. J Endourol 21:1113–1116PubMedCrossRef Nagele U, Horstmann M, Sievert KD et al (2007) A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in vitro pressure-measurement and microscopic study. J Endourol 21:1113–1116PubMedCrossRef
8.
Zurück zum Zitat Nagele U, Schilling D, Anastasiadis AG et al (2006) Closing the tract of mini-percutaneous nephrolithotomy with gelatine matrix hemostatic sealant can replace nephrostomy tube placement. Urology 68:489–493PubMedCrossRef Nagele U, Schilling D, Anastasiadis AG et al (2006) Closing the tract of mini-percutaneous nephrolithotomy with gelatine matrix hemostatic sealant can replace nephrostomy tube placement. Urology 68:489–493PubMedCrossRef
9.
Zurück zum Zitat Nagele U, Schilling D, Sievert KD et al (2008) Management of lower-pole stones of 0.8 to 1.5 cm maximal diameter by the minimally invasive percutaneous approach. J Endourol 22:1851–1853PubMedCrossRef Nagele U, Schilling D, Sievert KD et al (2008) Management of lower-pole stones of 0.8 to 1.5 cm maximal diameter by the minimally invasive percutaneous approach. J Endourol 22:1851–1853PubMedCrossRef
10.
Zurück zum Zitat Patel SR, Haleblian GE, Pareek G (2010) Percutaneous nephrolithotomy can be safely performed in the high-risk patient. Urology 75:51–55 Patel SR, Haleblian GE, Pareek G (2010) Percutaneous nephrolithotomy can be safely performed in the high-risk patient. Urology 75:51–55
11.
Zurück zum Zitat Schilling D, Gakis G, Walcher U et al. (2009) Minimally invasive percutaneous treatment of lower pole stones with a diameter of 8 to 15 Millimeters. Aktuelle Urol 40:351–354 Schilling D, Gakis G, Walcher U et al. (2009) Minimally invasive percutaneous treatment of lower pole stones with a diameter of 8 to 15 Millimeters. Aktuelle Urol 40:351–354
12.
Zurück zum Zitat Tanriverdi O, Boylu U, Kendirci M et al (2007) The learning curve in the training of percutaneous nephrolithotomy. Eur Urol 52:206–211PubMedCrossRef Tanriverdi O, Boylu U, Kendirci M et al (2007) The learning curve in the training of percutaneous nephrolithotomy. Eur Urol 52:206–211PubMedCrossRef
13.
Zurück zum Zitat Tefekli A, Ali Karadag M, Tepeler K et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53:184–190PubMedCrossRef Tefekli A, Ali Karadag M, Tepeler K et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53:184–190PubMedCrossRef
Metadaten
Titel
The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert
verfasst von
David Schilling
Georgios Gakis
Ute Walcher
Arnulf Stenzl
Udo Nagele
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 6/2011
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-010-0553-3

Weitere Artikel der Ausgabe 6/2011

World Journal of Urology 6/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.